- Home
- APRE vs LDWY Comparison
APRE vs LDWY Comparison
Compare APRE & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- LDWY
- Stock Information
- Founded
- APRE 2006
- LDWY 1990
- Country
- APRE United States
- LDWY United States
- Employees
- APRE N/A
- LDWY N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- LDWY Advertising
- Sector
- APRE Health Care
- LDWY Consumer Discretionary
- Exchange
- APRE Nasdaq
- LDWY Nasdaq
- Market Cap
- APRE 10.0M
- LDWY 9.2M
- IPO Year
- APRE 2019
- LDWY 1991
- Fundamental
- Price
- APRE $1.80
- LDWY $4.87
- Analyst Decision
- APRE Strong Buy
- LDWY
- Analyst Count
- APRE 2
- LDWY 0
- Target Price
- APRE $15.50
- LDWY N/A
- AVG Volume (30 Days)
- APRE 50.9K
- LDWY 4.7K
- Earning Date
- APRE 08-11-2025
- LDWY 08-18-2025
- Dividend Yield
- APRE N/A
- LDWY N/A
- EPS Growth
- APRE N/A
- LDWY N/A
- EPS
- APRE N/A
- LDWY N/A
- Revenue
- APRE $1,284,475.00
- LDWY $42,183,000.00
- Revenue This Year
- APRE N/A
- LDWY N/A
- Revenue Next Year
- APRE N/A
- LDWY N/A
- P/E Ratio
- APRE N/A
- LDWY N/A
- Revenue Growth
- APRE 33.27
- LDWY 425.12
- 52 Week Low
- APRE $1.41
- LDWY $3.02
- 52 Week High
- APRE $5.01
- LDWY $5.53
- Technical
- Relative Strength Index (RSI)
- APRE 49.58
- LDWY 50.30
- Support Level
- APRE $1.64
- LDWY $4.56
- Resistance Level
- APRE $1.81
- LDWY $5.30
- Average True Range (ATR)
- APRE 0.15
- LDWY 0.23
- MACD
- APRE -0.01
- LDWY -0.03
- Stochastic Oscillator
- APRE 51.76
- LDWY 44.16
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.